A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2022)